VOTRAGE
Phase 1 Terminated
18 enrolled
Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid Tumors
Phase 1 Terminated
91 enrolled
Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
Phase 1 Terminated
28 enrolled
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Phase 1 Terminated
34 enrolled
A Study of DS-9606a in Patients With Advanced Solid Tumors
Phase 1 Terminated
88 enrolled
A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
Phase 1 Terminated
35 enrolled
BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors
Phase 1 Terminated
99 enrolled
MAST
Phase 1 Terminated
66 enrolled
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.
Phase 1 Terminated
10 enrolled
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors
Phase 1 Terminated
21 enrolled
A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
Phase 1 Terminated
42 enrolled
PRIMING
Phase 1 Terminated
2 enrolled 10 charts
Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer
Phase 1 Terminated
3 enrolled
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 1 Terminated
79 enrolled 24 charts
POP-ART
Phase 1 Terminated
10 enrolled
A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer
Phase 1 Terminated
122 enrolled
KZR-261 in Subjects With Advanced Solid Malignancies
Phase 1 Terminated
61 enrolled 25 charts
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
Phase 1 Terminated
36 enrolled 7 charts
A Study of ASP2074 in Adults With Solid Tumors
Phase 1 Terminated
23 enrolled
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
Phase 1 Terminated
105 enrolled
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
Phase 1 Terminated
23 enrolled
To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550
Phase 1 Terminated
3 enrolled
A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Phase 1 Terminated
77 enrolled
A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas
Phase 1 Terminated
33 enrolled
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
Phase 1 Terminated
88 enrolled
A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors
Phase 1 Terminated
3 enrolled
Panthera
Phase 1 Terminated
2 enrolled
Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors
Phase 1 Terminated
3 enrolled 9 charts
A Study to Investigate LYL797 in Adults With Solid Tumors
Phase 1 Terminated
57 enrolled
A Study to Investigate LYL845 in Adults With Solid Tumors
Phase 1 Terminated
39 enrolled
A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Terminated
9 enrolled
A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma
Phase 1 Terminated
42 enrolled 28 charts
PROBE
Phase 1 Terminated
31 enrolled
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
Phase 1 Terminated
221 enrolled
Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).
Phase 1 Terminated
64 enrolled
RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer
Phase 1 Terminated
15 enrolled
Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)
Phase 1 Terminated
6 enrolled
ICVB-1042
Phase 1 Terminated
17 enrolled
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
Phase 1 Terminated
272 enrolled
Temsirolimus in Combination With Metformin in Patients With Advanced Cancers
Phase 1 Terminated
34 enrolled
Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies
Phase 1 Terminated
38 enrolled
Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer
Phase 1 Terminated
13 enrolled
QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast Cancer
Phase 1 Terminated
3 enrolled 10 charts
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants with Advanced Solid Tumors
Phase 1 Terminated
192 enrolled
Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)
Phase 1 Terminated
7 enrolled
Argonaut
Phase 1 Terminated
28 enrolled
First in Human Study of M1069 in Advanced Solid Tumors
Phase 1 Terminated
15 enrolled
A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread
Phase 1 Terminated
62 enrolled 30 charts
V938-001
Phase 1 Terminated
35 enrolled 21 charts
LTbR
Phase 1 Terminated
4 enrolled